BIOMAT Database Logo BIOMAT Database Logo

Successful management of refractory hypertension with dual calcium channel blocker therapy: case presentation. 1997

K Geurian, and D Lipschitz
Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock 72205, USA.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004095 Dihydropyridines Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

K Geurian, and D Lipschitz
Dual calcium-channel blocker therapy in the treatment of hypertension.
January 1996, The Annals of pharmacotherapy,
K Geurian, and D Lipschitz
Prolonged calcium channel blocker therapy of hypertension.
January 1988, Journal of cardiovascular pharmacology,
K Geurian, and D Lipschitz
[Calcium channel blocker for therapy of patients with hypertension].
August 1997, Nihon rinsho. Japanese journal of clinical medicine,
K Geurian, and D Lipschitz
Case studies in hypertension. Dihydropyridine/nondihydropyridine calcium channel blocker combination therapy.
January 2005, Journal of clinical hypertension (Greenwich, Conn.),
K Geurian, and D Lipschitz
Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations.
May 2009, Journal of cardiovascular pharmacology,
K Geurian, and D Lipschitz
Gynecomastia associated with calcium channel blocker therapy.
February 1988, Archives of internal medicine,
K Geurian, and D Lipschitz
Management of calcium channel blocker overdose.
March 2014, Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association,
K Geurian, and D Lipschitz
Management of calcium channel blocker overdoses.
October 2014, Journal of hospital medicine,
K Geurian, and D Lipschitz
Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study.
May 2023, Journal of clinical hypertension (Greenwich, Conn.),
K Geurian, and D Lipschitz
Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy.
January 1999, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!